Bump. All the florid optimism by the pump-apostles can not dispel the fact: ANX has been around for over 15 years and they haven't made a dime.
Sure, sure... it DOES take time to garner FDA approval.
But look at DEPO and other bio-pharms who have made it to market in a reasonable time and with reasonable pharmaceutical ventures.
One recent poster said of ANX's predicament regarding their candidate 530:
"The vials was thrown away on 530 the drug has not failed."
~***And this is your idea of defending this company's veracity? Give me a break.
(1) Longs are down big on this POS. They would love nothing more than to dump their shares at your expense.
(2) If you think that by buying 5,000 shares of a penny stock is your "risk-reward" strategy for making beau-coups bucks on a drug which is supposed to treat a number of maladies ("ischemia"- give it up dude: There are so many effective anticoagulants on the market already. 188 would be a johnny-come-lately AT BEST, and certainly would not be enough of an improvement over current meds to even warrant a carve-out of market share).
(3) And most importantly: ANX is a failure. Its success lies in its ability to continually recycle drug candidates for the purpose of finding new investing dupes to fund the lifestyles of the BOD. Please do your research on the history of this company and do not be fooled by the sanguine appeals of the ANX bag holders who are very under water with their "investment" in this sham.
*No, I am NOT a paid basher. If I could get paid for doing this, I still wouldn't do it.
*No, I am NOT a short. I have never shorted a stock in my life.